Here, using MK2Lyz2−KO mice, our study showed that MK2 contributes to the pathogenies of IBD by producing superfluous neutrophil-derived ROS both in vivo and in vitro. This evidence concerns the gene MAPKAPK2 and inflammatory bowel disease.